Fully Automated IIFT system

The UNIQO 160 is a state-of-the-art fully automated Immunofluorescence Test (IFT) system designed to streamline and optimize the entire process of IIFT from primary sample handling to the generation of final test results. Here’s a concise description of the UNIQO 160:

1. Immunofluorescence Testing Automation: The UNIQO 160 is dedicated to automating the entire process of Immunofluorescence Testing (IFT). IIFT is a vital technique used for detecting and identifying specific antibodies in patient sera, commonly employed in the diagnosis of autoimmune diseases.
2. End-to-End Automation: This system automates every step of the IIFT workflow, starting from the processing of primary patient samples, sample dilution, incubation, slide preparation, imaging, pattern recognition, and result generation. It reduces the need for manual labor and minimizes the potential for human error.
3. High Throughput: The UNIQO 160 is capable of handling a large number of samples simultaneously, making it highly suitable for laboratories with substantial testing volumes. It significantly improves laboratory efficiency and shortens turnaround times.
4. Advanced Imaging and Pattern Recognition: Equipped with advanced imaging technology and pattern recognition algorithms, the system captures high-resolution images of fluorescent patterns and automatically interprets and classifies the patterns. This ensures accurate and consistent results.
5. User-Friendly Interface: The UNIQO 160 is typically equipped with a user-friendly software interface that simplifies system operation, monitoring, and result review. Laboratory personnel can easily navigate the system.
6. Data Management: The system efficiently manages and archives the data generated during IIFT tests, ensuring traceability and data integrity.
7. Quality Control: Built-in quality control measures and monitoring features maintain the accuracy and reliability of IIFT results, aligning with regulatory standards and ensuring high-quality outcomes.
8. Applications: The UNIQO 160 is utilized in clinical laboratories for the diagnosis and monitoring of autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, and antinuclear antibody (ANA)-associated conditions.

In summary, the UNIQO 160 is a cutting-edge fully automated IIFT system that optimizes the entire IIFT workflow, from sample processing to final result generation. Its high throughput, precision, automation capabilities, and user-friendly interface make it an indispensable tool for laboratories conducting IIFT assays for diagnostic and research purposes.